vimarsana.com
Home
Live Updates
Placebo Controlled Multicenter Study - Breaking News
Pages:
Latest Breaking News On - Placebo controlled multicenter study - Page 1 : vimarsana.com
Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an infectious pathogen’s virulence factors to reduce damage and mitigate disease .
United states
Lisam wilson
Valentin curt
Eagle pharmaceuticals
Globenewswire inc
Eagle pharmaceuticals inc
Site communications inc
Severe community
Drug administration
Company annual report on form
Clinical drug development
Acacia pharma inc
Company quarterly report on form
American society for microbiology
Exchange commission
European society for clinical microbiology
vimarsana © 2020. All Rights Reserved.